GGrantIndex
Sort

64,565 grants matching drug discovery

Development of Brain MRI Contrast Agents

$1,613,730
Alan Koretsky · National Institute Of Neurological Disorders And Stroke · ZIA · FY2019 · NS

SPORE in GI Cancer

$1,612,852
Robert J Coffey · Vanderbilt University · P50 · FY2013 · CA

Translational center for kidney microphysiological systems to improve drug safety and efficacy

$1,612,823
Jonathan Himmelfarb · Icahn School Of Medicine At Mount Sinai · U2C · FY2025 · TR

Bacteria and Host in TB Transmission

$1,612,367
David Alland · Rutgers Biomedical And Health Sciences · R01 · FY2025 · AI

Novel therapies to inhibit diabetic retinopathy

$1,611,990
Timothy S Kern · Case Western Reserve University · R24 · FY2018 · EY

Translational Immunology research: a support for clinical immunological research

$1,610,954
Massimo Gadina · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIC · FY2018 · AR

Design And Development Of Experimental Therapeutics

$1,610,701
Nigel H. Greig · National Institute On Aging · ZIA · FY2011 · AG

Rare Disease Network for Myasthenia Gravis

$1,610,173
Henry J Kaminski · George Washington University · U54 · FY2019 · NS

Discovery of Drugs that Modulate Neuroinflammation for the treatment of Alzheimer's Disease

$1,609,985
Kevin Hodgetts · Brigham And Women'S Hospital · U01 · FY2022 · AG

Defining RAS isoform- and mutation-specific roles in oncogenesis

$1,609,721
Channing J Der · Univ Of North Carolina Chapel Hill · P01 · FY2016 · CA

Nephrotic Syndrome Rare Disease Clinical Research Network III

$1,609,672
Matthias Kretzler · University Of Michigan At Ann Arbor · U54 · FY2019 · DK

Defining RAS isoform- and mutation-specific roles in oncogenesis

$1,609,444
Channing J Der · Univ Of North Carolina Chapel Hill · P01 · FY2020 · CA

Structure Biology and Targeted Drug Design for AIDS

$1,608,890
Paul R Ortiz De Montellano · University Of California, San Francisco · P01 · FY2006 · GM

Advancing Epilepsy Diagnosis with Flexible, High-Resolution Thin-Film Electrodes

$1,608,204
Daniel Friedman · New York University School Of Medicine · UG3 · FY2024 · NS

Wake Forest Translational Alcohol Research Center (WF-TARC)

$1,607,584
Jeffrey L. Weiner · Wake Forest University Health Sciences · P50 · FY2019 · AA

Emory/Atlanta Center for AIDS Research

$1,607,431
James W. Curran · Emory University · P30 · FY2007 · AI

Chemical Countermeasures Collaboration: Chemical Threats Affecting Cellular Respiration

$1,607,103
Office Of The Director, National Institutes Of Health · Y01 · FY2024 · OD

The Ohio State University as a Lead Academic Organization (LAO) for the Experimental Therapeutics Clinical Trials Network

$1,607,030
William E. Carson · Ohio State University · UM1 · FY2024 · CA

Cellular and Molecular Physiology of Bloodstream Malaria Parasites

$1,606,900
Sanjay A Desai · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

Novel Chemical and Immunological Approaches to Influenza Therapy

$1,606,853
Michael B Oldstone · Scripps Research Institute, The · U01 · FY2007 · AI

Novel Protein Biomarkers of Corticolimbic Pathophysiology in Lewy body Dementia

$1,606,305
Nicholas Thomas Seyfried · Emory University · U01 · FY2023 · NS

Wake Forest Translational Alcohol Research Center (WF-TARC)

$1,605,748
Jeffrey L. Weiner · Wake Forest University Health Sciences · P50 · FY2018 · AA

Cellular and Molecular Physiology of Bloodstream Malaria Parasites

$1,605,646
Sanjay A Desai · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI

Structural basis for the functions of dopamine receptors, neurotransmitter transporters, and sigma 1 receptor

$1,605,608
Lei Shi · National Institute On Drug Abuse · ZIA · FY2019 · DA

Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD

$1,604,844
Rima F Kaddurah-Daouk · Duke University · U01 · FY2020 · AG